Impact of drug therapy on benign prostatic hyperplasia-specific quality of life

This publication has 23 references indexed in Scilit:

• Construction and validation of a short-form benign prostatic hypertrophy health-related quality-of-life questionnaire
  BJU International, 1997
• Quality of Life in Geriatric Patients With Lower Urinary Tract Dysfunction
  The Lancet Healthy Longevity, 1997
• Relative Importance of Sexuality and Quality of Life in Patients with Prostatic Symptoms
  European Urology, 1997
• Placebo Effects in the Pharmacological Treatment of Uncomplicated Benign Prostatic Hyperplasia
  Scandinavian Journal of Urology and Nephrology, 1996
• Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials
  Urology, 1996
• Benign Prostatic Hyperplasia Specific Health Status Measures in Clinical Research: How Much Change in the American Urological Association Symptom Index and the Benign Prostatic Hyperplasia Impact Index is Perceptible to Patients?
  Published by Wolters Kluwer Health ,1995
• A Comparison of Transurethral Surgery with Watchful Waiting for Moderate Symptoms of Benign Prostatic Hyperplasia
  New England Journal of Medicine, 1995
• Long-Term Quality of Life in Patients with Benign Prostatic Hypertrophy: Preliminary Results of a Cohort Survey of 7,093 Patients Treated with an Alpha-1 - Adrenergic Blocker, Alfuzosin
  European Urology, 1993
• Symptom status and quality of life following prostatectomy
  JAMA, 1988
• The Natural History of Untreated “Prostatism”
  British Journal of Urology, 1981